LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
1 - 2 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Serum (preferred) or plasma
1 mL (adult), 0.5 mL (pediatric)
Red-top tube, gel-barrier tube, or green-top (heparin) tube.
Remove serum or plasma within 45 minutes and transfer to a plastic transport tube. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.
Excessive lipemia (>1500 mg/dL) significantly increases the apparent C3 concentration.
Quantitation of C3 is used to detect individuals with inborn deficiency of this factor or those with immunologic disease in whom complement is consumed at an increased rate. These include lupus erythematosus, chronic active hepatitis, certain chronic infections, poststreptococcal and membranoproliferative glomerulonephritis, and others.
Detects both biologically active and inactive C3
0 to 14
15 to 30
C3 comprises about 70% of the total protein in the complement system and is central to activation of both the classical and alternate pathways. Increased levels are found in numerous inflammatory states as an acute phase response. CH50 (total complement hemolytic activity), C3 and/or C4 may be decreased in cases of systemic lupus erythematosus, especially in cases with lupus nephritis, acute and chronic hypocomplementemic nephritis, subacute bacterial endocarditis, DIC, and partial lipodystrophy (with associated nephritis-like activity in serum.) In cases of disseminated intravascular coagulation, plasmin attacks C3 directly, and C3 levels have been found low in the hemolytic uremic syndrome form of disseminated intravascular coagulation (DIC). Cases of hereditary C3 deficiency, while rare, have been reported and are characterized clinically by recurrent infections (eg, pneumonia, meningitis, paronychia, impetigo). Pathogenic bacteria causing infections in these cases have included both gram-positive and gram-negative organisms. C3 levels have also been found deficient in cases of uremia, chronic liver diseases, anorexia nervosa, and celiac disease.
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|006452||Complement C3, Serum||4485-9||006453||Complement C3, Serum||mg/dL||4485-9|
© 2019 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
The LOINC® codes are copyright © 1994-2018, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf